(Copenhagen:ZEAL), Press release – No. 2 / 2026 Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy Access to Gefion, Denmark's flagship AI supercomputer, gives Zealand Pharma access to unprecedented computational power, enabling large-scale modeling, prediction, and optimization of drug candidates Agreement will […]

(Paris:TNG), TG4050 elicits strong polyepitopic, polyclonal, durable cytotoxic and effector neoantigen-specific CD8 T cell responses Results reinforce TG4050 potential as an individualized cancer immunotherapy Strasbourg, France, January 9, 2026, 8:00 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced the preprint

Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, today announced an integrated drug discovery collaboration to identify and develop novel small-molecule drug candidates in oncology. This initiative reflects both companies’ commitment to advancing oncology research by integrating complementary strengths across computational design, medicinal chemistry, biology, medical

ASE Technology Holding Co., Ltd. (NYSE: ASX, TAIEX: 3711, “ASEH” or the “Company”), announces its unaudited consolidated net revenues for December, 4th quarter and full year of 2025. CONSOLIDATED NET REVENUES (UNAUDITED) Dec Nov Dec Sequential YoY (NT$ Million) 2025 2025 2024 Change Change Net Revenues 58,865 58,820 52,905 +0.1 % +11.3 % Dec Nov

Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy GlobeNewswire January 09, 2026 Press release – No. 2 / 2026 Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy Access to

Transgene Publishes Phase I Data Supporting TG4050's Potential in Preventing Head and Neck Cancer Relapse GlobeNewswire January 09, 2026 TG4050 elicits strong polyepitopic, polyclonal, durable cytotoxic and effector neoantigen-specific CD8 T cell responses Results reinforce TG4050 potential as an individualized cancer immunotherapy Strasbourg, France, January 9, 2026, 8:00 a.m. CET – Transgene (Euronext Paris: TNG),

Pulsar Helium Reports Additional High-Pressure Gas Encounter at Jetstream #5 and Outlines Upcoming Testing Program GlobeNewswire January 09, 2026 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH

The Global Top Brands Award Ceremony and International Consumer Electronics Industry Leaders' Summit were held in Las Vegas on January 7, 2026 during the Consumer Electronics Show (CES), a major event in the global consumer electronics industry. This event marked the 20th anniversary of the Global Top Brands (GTB) selection. Founded by International Data Group

Glendale, CA, Jan. 09, 2026 (GLOBE NEWSWIRE) — The update strengthens RadCred's loan-matching process, supporting faster loan decision timelines through licensed lenders. RadCred announced an update to its online loan-matching platform that enables borrowers with bad or limited credit to access same-day loan approval options through licensed lenders. The update comes at a time when

Same-Day Loans Guaranteed Approval and No Credit Check for Bad Credit Borrowers Introduced by RadCred RadCred announces an update to its loan-matching platform, helping borrowers with bad credit access same-day loan options from licensed lenders. GlobeNewswire January 09, 2026 Glendale, CA, Jan. 09, 2026 (GLOBE NEWSWIRE) — The update strengthens RadCred's loan-matching process, supporting faster